GetTopicDetailResponse(id=28706e01632, topicName=炎癥微環(huán)境, introduction=炎癥微環(huán)境, content=null, image=null, comments=1, allHits=1724, url=https://h5.medsci.cn/topic?id=67016, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=78693, tagList=[TagDto(tagId=78693, tagName=炎癥微環(huán)境)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2214904, encodeId=3deb221490413, content=<a href='/topic/show?id=4a378461064' target=_blank style='color:#2F92EE;'>#脊髓損傷#</a> <a href='/topic/show?id=28706e01632' target=_blank style='color:#2F92EE;'>#炎癥微環(huán)境#</a> <a href='/topic/show?id=028711664383' target=_blank style='color:#2F92EE;'>#漢黃芩素#</a> <a href='/topic/show?id=406c11664404' target=_blank style='color:#2F92EE;'>#導(dǎo)電明膠水凝膠#</a>, objectTitle=中藥小分子緩釋導(dǎo)電水凝膠促進(jìn)脊髓損傷后運動和膀胱功能恢復(fù), objectType=article, longId=834417, objectId=3e1083441e37, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240714/1720950459912_5579292.jpg, objectUrl=/article/show_article.do?id=3e1083441e37, replyNumber=0, likeNumber=132, createdTime=2024-07-14, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3e1083441e37, moduleTitle=中藥小分子緩釋導(dǎo)電水凝膠促進(jìn)脊髓損傷后運動和膀胱功能恢復(fù), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3e1083441e37)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2121507, encodeId=b573212150e59, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a></a><a href='/topic/show?id=28706e01632' target=_blank style='color:#2F92EE;'>#炎癥微環(huán)境#</a>由多種免疫細(xì)胞、非血源性間質(zhì)細(xì)胞、以及多種<a href='/topic/show?id=a13466968af' target=_blank style='color:#2F92EE;'>#炎性#</a>介質(zhì)組成。肝癌進(jìn)展過程中，免疫抑制因素占據(jù)優(yōu)勢，削弱抗腫瘤免疫。因此，深入探討肝癌的免疫調(diào)節(jié)機制，有助于開發(fā)肝癌的免疫治療新策略。Chemerin是一個新發(fā)現(xiàn)的炎癥相關(guān)蛋白，文獻(xiàn)報道和我們的研究揭示chemein通過多種機制調(diào)節(jié)炎癥。
Chemerin, also known as retinoic acid receptor responder protein 2 (RARRES2), tazarotene-induced gene 2 protein (TIG2), or RAR-responsive protein TIG2 is a protein that in humans is encoded by the RARRES2 gene，Chemerin has been implicated in autocrine / paracrine signaling for adipocyte differentiation and also stimulation of lipolysis。chemein主要在<a href='/topic/show?id=3ad9818917c' target=_blank style='color:#2F92EE;'>#肥胖#</a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>中起關(guān)鍵作用，與腫瘤并不密切??！但是，確實可能影響到<a href='/topic/show?id=f0838291817' target=_blank style='color:#2F92EE;'>#腫瘤微環(huán)境#</a>，也許是<a href='/topic/show?id=85d999e268a' target=_blank style='color:#2F92EE;'>#非酒精性脂肪肝#</a>向<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a></a>發(fā)展的重要趨動因素之一，有興趣的朋友可以順著我的方向進(jìn)行研究。, objectTitle=Chemerin抑制肝癌及調(diào)控肝癌炎癥微環(huán)境的機制研究, objectType=nsfc, longId=385512, objectId=1dbe385512b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/sci/nsfc_show.do?id=1dbe385512b8, replyNumber=0, likeNumber=312, createdTime=2023-03-24, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1dbe385512b8, moduleTitle=Chemerin抑制肝癌及調(diào)控肝癌炎癥微環(huán)境的機制研究, moduleType=nsfc, hrefUrl=http://ermita.cn/sci/nsfc_show.do?id=1dbe385512b8)], followStatus=false, userIsMember=false, type=1, lengthMark=1)]
梅斯話題小助手
關(guān)注
已關(guān)注
2020-05-29
前往app查看評論內(nèi)容
全文
收起
#肝癌# #炎癥微環(huán)境# 由多種免疫細(xì)胞、非血源性間質(zhì)細(xì)胞、以及多種#炎性# 介質(zhì)組成。肝癌進(jìn)展過程中，免疫抑制因素占據(jù)優(yōu)勢，削弱抗腫瘤免疫。因此，深入探討肝癌的免疫調(diào)節(jié)機制，有助于開發(fā)肝癌的免疫治療新策略。Chemerin是一個新發(fā)現(xiàn)的炎癥相關(guān)蛋白，文獻(xiàn)報道和我們的研究揭示chemein通過多種機制調(diào)節(jié)炎癥。
Chemerin, also known as retinoic acid receptor responder protein 2 (RARRES2), tazarotene-induced gene 2 protein (TIG2), or RAR-responsive protein TIG2 is a protein that in humans is encoded by the RARRES2 gene，Chemerin has been implicated in autocrine / paracrine signaling for adipocyte differentiation and also stimulation of lipolysis。chemein主要在#肥胖# #糖尿病# 中起關(guān)鍵作用，與腫瘤并不密切?。〉?，確實可能影響到#腫瘤微環(huán)境# ，也許是#非酒精性脂肪肝# 向#肝癌# 發(fā)展的重要趨動因素之一，有興趣的朋友可以順著我的方向進(jìn)行研究。
